SEC Form 4 · accession 0001450324-18-000005
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas K. Equels
Officer — Exec. Vice Chairman/CEO/Pres. · Director
Period of report
Jul 27, 2018
Accepted (ET)
Jul 27, 2018 · 9:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2018 | P | 34,483 | $0.29 | A | 672,306 | D |
Table II — derivative securities
No Table II lines on this filing.